LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via downregulation of PI3K activity

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3103-3107

  Gong, Chen ^a   Liao, Hui ^a   Wang, Jiang ^a   Lin, Yang ^a   Qi, Jun ^a   Qin, Liang ^a   Tian, Lin Qiang ^a   Guo, Feng Jing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Cancer stem like cells; Cell cycle; Osteosarcoma; PI3K Akt pathway

Indexed keywords

EID: 84873577930     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3103     Document Type: Article

References (24)

1. Casagrande F, Bacqueville D, Pillaire MJ, et al (1998). G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells. FEBS Lett, 422, 385-90.
2. Coffey JC, Wang JH, Smith MJ, et al (2005). Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy. J Biol Chem, 280, 20968-77.
3. Dick JE (2008). Stem cell concepts renew cancer research. Blood, 112, 4793-807.
4. Eyler CE, Foo WC, LaFiura KM, et al (2008). Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells, 26, 3027-36.
5. Frank NY, Schatton T, Frank MH (2010). The therapeutic promise of the cancer stem cell concept. J Clin Invest, 120, 41-50.
6. Gibbs CP, Kukekov VG, Reith JD, et al (2005). Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 7, 967-76.
7. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
8. Jiang H, Fan D, Zhou G, Li X, Deng H (2010). Phosphatidylinositol 3-kinase inhibitor (LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo. J Exp Clin Cancer Res, 29, 34.
9. Lee CM, Fuhrman CB, Planelles V, et al (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res, 12, 250-6.
10. Liu B, Ma W, Jha RK, Gurung K (2011). Cancer stem cells in osteosarcoma: recent progress and perspective. Acta Oncol, 50, 1142-50.
11. Luan Y, Yang Q, Xie Y, et al (2011). A sensitive near-infrared fluorescent probe for caspase-mediated apoptosis: Synthesis and application in cell imaging. Drug Discov Ther, 5, 220-6.
12. Meyers PA, Schwartz CL, Krailo M, et al (2005). Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol, 23, 2004-11.
13. Rosen JM, Jordan CT (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324, 1670-3.
14. Semba S, Itoh N, Ito M, Harada M, Yamakawa M (2002). The in vitro and in vivo effects of 2-(4-morpholinyl)- 8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells. Clin Cancer Res, 8, 1957-63.
15. Teranishi F, Takahashi N, Gao N, et al (2009). Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo. Cancer Sci, 100, 770-7.
16. Tirino V, Desiderio V, D'Aquino R, et al (2008). Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One, 3, e3469.
17. Veselska R, Hermanova M, Loja T, et al (2008). Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer, 8, 300.
18. Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68.
19. Walker EH, Pacold ME, Perisic O, et al (2000). Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell, 6, 909-19.
20. Wilson H, Huelsmeyer M, Chun R, et al (2008). Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J, 175, 69-75.
21. Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M (2003). Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood, 102, 972-80.
22. Zhang F, Chen A, Chen J, Yu T, Guo F (2011). SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells. Asian Pac J Cancer Prev, 12, 239-45.
23. Zhang Y, Johansson E, Miller ML, et al (2011). Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway. PLoS One, 6, e25284.
24. Zhao C, Chen A, Jamieson CH, et al (2009). Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature, 458, 776-9.